BioCina

BioCina is a global CDMO offering top-tier quality, regulatory compliance, and industry-leading on-time delivery. With expertise in small molecules, microbial, pDNA, and mRNA, BioCina provides cell line development, process development, analytics, formulation, and cGMP manufacturing. Operating in Adelaide and Perth, its facilities have a strong regulatory record with approvals from the US FDA, EMA, Health Canada, and TGA. Serving global clients, BioCina focuses solely on manufacturing. Australia’s tax incentives (up to 48.5% cash refund) make it an ideal location for drug developers.